Mersana Therapeutics, Inc.
MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF
Last updated:
Abstract:
This invention provides fully human monoclonal antibodies that recognize HER2. The invention further provides methods of using such monoclonal antibodies in a variety of therapeutic, diagnostic, and prophylactic indications.
Status:
Application
Type:
Utility
Filling date:
2 Oct 2019
Issue date:
30 Jan 2020